Cytokines and prostaglandins in immune homeostasis and tissue destruction in periodontal disease
1997; Wiley; Volume: 14; Issue: 1 Linguagem: Inglês
10.1111/j.1600-0757.1997.tb00194.x
ISSN1600-0757
AutoresE. Gemmell, Roderick I. Marshall, G. J. Seymour,
Tópico(s)Immune Response and Inflammation
ResumoPeriodontology 2000Volume 14, Issue 1 p. 112-143 Cytokines and prostaglandins in immune homeostasis and tissue destruction in periodontal disease ERICA GEMMELL, ERICA GEMMELLSearch for more papers by this authorRODERICK I. MARSHALL, RODERICK I. MARSHALLSearch for more papers by this authorGREGORY J. SEYMOUR, GREGORY J. SEYMOURSearch for more papers by this author ERICA GEMMELL, ERICA GEMMELLSearch for more papers by this authorRODERICK I. MARSHALL, RODERICK I. MARSHALLSearch for more papers by this authorGREGORY J. SEYMOUR, GREGORY J. SEYMOURSearch for more papers by this author First published: 23 February 2007 https://doi.org/10.1111/j.1600-0757.1997.tb00194.xCitations: 259AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Allison JP. CD27-B7 interactions in T-cell activation. Curr Opin Immunol 1994: 6: 414–419. 2 Angelini SM, Trevino AC, Novak MJ. Mechanisms of neutrophil immobilization by membrane vesicles of Porphyromonas gingivalis. J Dent Res 1994: 73: 347 (abstr 1961). 3 Anderson W. Human gene therapy. Science 1992: 256: 808–813. 4 Aoyagi T, Sugawara-Aoyagi M, Yamazaki K, Hara K. Interleukin 4 (IL-4) and IL-6-producing memory T-cells in peripheral blood and gingival tissues in periodontitis patients with high serum antibody titers to Porphyromonas gingivalis. Oral Microbiol Immunol 1995: 10: 304–310. 5 Arai H, Nomura Y, Kinoshita M, Shimizu H, Ono K, Goto H, Takigawa M, Nishimura F, Washio N, Kurihara H, Murayama Y. Response of human gingival fibroblasts to prostaglandins. J Periodont Res 1995: 30: 303–311. 6 Arend WP. Interleukin 1 receptor antagonist. A new member of the interleukin 1 family. J Clin Invest 1991: 88: 1445–1451. 7 Asnis L, Gaspari A. Cutaneous reactions to recombinant cytokine therapy. J Am Acad Dermatol 1995: 33: 393–410. 8 Attström R, Egelberg J. Emigration of blood neutrophils and monocytes into the gingival crevice. J Periodont Res 1970: 5: 48–55. 9 Attström R. Studies on neutrophil polymorphonuclear leukocytes at the dento-gingival junction in gingival health and disease. J Periodont Res 1971: 8(suppl): 1–15. 10 Audibert FM, Lise LD. Adjuvants: current status, clinical perspectives and future prospects. Immunol Today 1993: 14: 281–284. 11 Balkwill FR, Burke F. The cytokine network. Immunol Today 1989: 9: 299–304. 12 Bancroft GJ. The role of natural killer cells in innate resistance to infection. Curr Opin Immunol 1993: 5: 503–510. 13 Barnes PJ, Adcock I. Anti-inflammatory actions of steroids: molecular mechanisms. Trends Pharmacol Sci 1993: 14: 436–441. 14 Barnett J, Chow J, Ives D, Chiou M, Mackenzie R, Osen E, Nguyen B, Tsing S, Bach C, Freire J, Chan H, Sigal E, Ramesha C. Purification, characterization and selective inhibition of human prostaglandin G/H synthase 1 and 2 expressed in the baculovirus system. Biochim Biophys Acta 1994: 1209: 130–139. 15 Bertolini DR, Nedwin GE, Bringman JS, Smith DD, Mundy GR. Stimulation of bone resorption and inhibition of formation in vitro by human tumor necrosis factors. Nature 1986: 319: 516–518. 16 Bevilacqua MP, Pober JS, Wheeler ME, Cotran RS, Gimbrone MA Jr. Interleukin 1 acts on cultured human vascular endothelium to increase the adhesion of polymorphonuclear leukocytes, monocytes, and related leukocyte cell lines. J Clin Invest 1985: 76: 2003–2011. 17 Bigler CF, Norris DA, Weston WL, Arend WP. Interleukin-1 receptor antagonist production by human keratinocytes. J Invest Dermatol 1992: 98: 38–44. 18 Birkedal-Hansen H. Roles of cytokines and inflammatory mediators in tissue destruction. J Periodont Res 1993: 28: 500–510. 19 Blau H, Springer M. Gene therapy - a novel form of drug delivery. N Engl J Med 1995: 333: 1204–1207. 20 Bloom BR, Salgame P, Diamond B. Revisiting and revising suppressor T cells. Immunol Today 1992: 13: 131–136. 21 Bohjanen PR, Okajima M, Hodes RJ. Differential regulation of interleukin 4 and interleukin 5 gene expression: a comparison of T-cell gene induction by anti-CD3 antibody or by exogenous lymphokines. Proc Natl Acad Sci U S A 1990: 87: 5283–5287. 22 Bookstein R, Demers W, Gregory R, Manevol D, Park J, Wills K. p53 gene therapy in vivo of hepatocellular and liver metastatic colorectal cancer. Semin Oncol 1996: 23: 101–107. 23 Boyce S, Chan CC, Gordon R, Li CS, Rodger IW, Webb JK, Rupniak NM, Hill RG. L-745,337: a selective inhibitor of cyclooxygenase-2 elicits antinociception but not gastric ulceration in rats. Neuropharmacol 1994: 33: 1609–1611. 24 Brach MA, DeVos S, Gruss HJ, Herrmann F. Prolongation of survival of human polymorphonuclear neutrophils by granulocyte-macrophage colony-stimulating factor is caused by inhibition of programmed cell death. Blood 1992: 80: 2920–2924. 25 Brown M, Hu-Li J, Paul WE. IL-4/B cell stimulatory factor 1 stimulates T cell growth by an IL-2-independent mechanism. J Immunol 1988: 131: 504–511. 26 Caillon P, Saffar J. Improvement of gingival and alveolar bone status in periodontitis-affected hamsters treated with 15-methyl prostaglandin E1. J Periodont Res 1994: 29: 138–45. 27 Carpenter AB, Sully EC, Ranney RR, Bick PH. T-cell regulation of polyclonal B-cell activation induced by extracts of oral bacteria associated with periodontal diseases. Infect Immun 1984: 43: 326–336. 28 Carter LL, Dutton RW. Type 1 and Type 2: a fundamental dichotomy for all T-cell subsets. Curr Opin Immunol 1996: 8: 336–342. 29 Cassatella MA, Gasperini S, Calzetti F, McDonald PP, Trinchieri G. Lipopolysaccharide-induced interleukin-8 gene expression in human granulocytes: transcriptional inhibition by interferon-gamma. Biochem J 1995: 310: 751–755. 30 Cassatella MA, Meda L, Bonora S, Ceska M, Constantin G. Interleukin 10 (IL-10) inhibits the release of proinflammatory cytokines from polymorphonuclear leukocytes. Evidence for an autocrine role of tumor necrosis factor and IL-1 beta in mediating the production of IL-8 triggered by lipopolysaccharide. J Exp Med 1993: 178: 2207–2211. 31 Cassatella MA, Meda L, Gasperini S, Calzetti F, Bonora S. Interleukin 10 (IL-10) upregulates IL-1 receptor antagonist production from lipopolysaccharide-stimulated human polymorphonuclear leukocytes by delaying mRNA degradation. J Exp Med 1994: 179: 1695–1699. 32 Centrella M, McCarthy TL, Canalis E. Skeletal tissue and transforming growth factor β. FASEB J 1988: 2: 3066–3073. 33 Chan C, Boyce S, Brideau C, Ford Hutchinson AW, Gordon R, Guay D, Hill RG, Li CS, Mancini J, Penneton M, Prasit P, Rasori R, Riendeau D, Roy D, Tagari P, Vickers P, Wong E, Rodger I. Pharmacology of a selective cyclooxygenase-2 inhibitor, L-745,337: a novel nonsteroidal anti-inflammatory agent with an ulcerogenic sparing effect in rat and nonhuman primate stomach. J Pharmacol Exp Ther 1995: 274: 1531–1537. 34 Chan SH, Perussia B, Gupta JW, Kobayashi M, Pospisil M, Young HA, Wolf SF, Young D, Clark SC, Trinchieri G. Induction of interferon gamma production by natural killer cell stimulatory factor: characterization of the responder cells and synergy with other inducers. J Exp Med 1991: 173: 869–879. 35 Chanmugam P, Feng L, Liou S, Jang BC, Boudreau M, Yu G, Lee JH, Kwon HJ, Beppu T, Yoshida M, Xia Y, Wilson C, Hwang D. Radicicol, a protein tyrosine kinase inhibitor, suppresses the expression of mitogen-inducible cyclooxygenase in macrophages stimulated with lipopolysaccharide and in experimental glomerulonephritis. J Biol Chem 1995: 270: 5418–5426. 36 Chen PB, Davern LB, Schifferle R, Zambon JJ. Protective immunization against experimental Bacteroides (Porphyromonas) gingivalis infection. Infect Immun 1990: 58: 3394–3400. 37 Clagett JA, Page RC. Insoluble immune complexes and chronic periodontal diseases in man and the dog. Arch Oral Biol 1978: 23: 153–165. 38 Clemens MJ. In: AP Read, T. Brown ed. Cytokines. Oxford : Bios Scientific Publishers, 1991. 39 Coffman RL, Carty J. A T cell activity that enhances polyclonal IgE production and its inhibition by interferongamma. J Immunol 1986: 136: 949–954. 40 Coffman RL, Ohara J, Bond MW, Carty J, Zlotnik A, Paul WE. B cell stimulatory factor-1 enhances the IgE response of lipopolysaccharide-activated B cells. J Immunol 1986: 136: 4538–4541. 41 Cole KC, Seymour GJ, Powell RN. The autologous mixed lymphocyte reactions (AMLR) using periodontal lymphocytes. J Dent Res 1986: 65: 473, abstract no. 16. 42 Cole KC, Seymour GJ, Powell RN. Phenotypic and functional analysis of T cells extracted from chronically inflamed human periodontal tissues. J Periodontol 1987: 58: 469–573. 43 Colombo M, Rodolfo M. Tumor cells engineered to produce cytokines or cofactors as cellular vaccines: do animal studies really support clinical trials. Cancer Immunol Immunother 1995: 41: 265–270. 44 Colotta F, Re F, Polentarutti N, Sozzani S, Mantovani A. Modulation of granulocyte survival and programmed cell death by cytokines and bacterial products. Blood 1992: 80: 2012–2020. 45 Cominelli F, Nast CC, Clark BD, Schindler R, Lierena R, Eysselein VE, Thompson RC, Dinarello CA. Interleukin 1 (IL-1) gene expression, synthesis, and effect of specific IL-1 receptor blockade in rabbit immune complex colitis. J Clin Invest 1990: 86: 972–980. 46 Cope AP, Aderka D, Doherty M, Engelmann H, Gibbons D, Jones AC, Brennan FM, Maini RN, Wallach D, Feldmann M. Increased levels of soluble tumor necrosis factors in the sera and synovial fluid of patients with rheumatic diseases. Arthritis Rheum 1992: 35: 1160–1169. 47 Cosman D, Lyman SD, Idzerda RL, Beckmann MP, Park LS, Goodwin RG, March CJ. A new cytokine receptor superfamily. Trends Biochem Sci 1990: 15: 265–270. 48 Crystal R, McElvaney N, Rosenfeld M, Chu C-S, Mastrangeli A, Hay JG, Brody SL, Jaffe HA, Eissa NT, Danel C. Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis. Nature Genet 1994: 8: 42–47. 49 Curiel D, Wagner E, Cotten M, Birnstiel M, Agarwal S, Li CM, Loechel S, Hu PC. High efficiency gene transfer mediated by adenovirus coupled to DNA-polylysine complexes. Hum Gene Ther 1992: 3: 147–154. 50 Dayer JM, Beutler B, Cerami A. Cachectin/tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts. J Exp Med 1985: 162: 2163–2168. 51 De Maeyer E, De Maeyer-Guignard J. Interferon-γ. Curr Opin Immunol 1992: 4: 321–326. 52 Del Prete G, De Carli M, Almerigogna F, Giudizi MG, Biagiotti R, Romagnani S. Human IL-10 is produced by both Type 1 helper (Th1) and Type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine production. J Immunol 1993: 150: 353–360. 53 Del Prete G, Maggi E, Parronchi P, Chretien I, Tiri A, Macchia D, Ricci M, Banchereau J, De Vries J, Romagnani S. IL-4 is an essential factor for the IgE synthesis induced in vitro by human T cell clones and their supernatants. J Immunol 1988: 140: 4193–4198. 54 De Waal Malefyt R, Yssel H, de Vries JE. Direct effects of IL-10 on subsets of human CD4+ T cell clones and resting T cells. Specific inhibition of IL-2 production and proliferation. J Immunol 1993: 150: 4754–4765. 55 De Waal Malefyt R, Figdor C, Huijbens R, Mohan-Peterson S, Bennett B, Culpepper J, Dang W, Zurawski G, de Vries JE. Effects of IL-13 on phenotype, cytokine production, and cytotoxic function of human monocytes. J Immunol 1993: 151: 6370–6381. 56 De Waal Malefyt R, Yssel H, Roncarolo M-G, Spits H, de Vries JE. Interleukin-10. Curr Opin Immunol 1992: 4: 314–320. 57 Dewhirst F, Moss D, Offenbacher S, Goodson JM. Levels of prostaglandin E2, thromboxane, and prostacyclin in periodontal tissues. J Periodont Res 1983: 18: 156–163. 58 Dietrich J, Goodson JM, Raisz LG. Stimulation of bone resorption by various prostaglandins in organ culture. Prostaglandins 1975: 10: 231–240. 59 Dinarello CA. Interleukin-1. Rev Infect Dis 1984: 6: 51–95. 60 Dinarello CA. The biology of interleukin 1 and comparison to tumor necrosis factor. Immunol Lett 1987: 16: 227–232. 61 Dinarello CA. The role of interleukin-1 in host responses to infectious diseases. Infect Agents Dis 1992: 1: 227–236. 62 Dinarello CA, Wolff SM. The role of interleukin-1 in disease. N Engl J Med. 1993: 328: 106–113. 63 Ding L, Shevach EM. IL-10 inhibits mitogen-induced T cell proliferation by selectively inhibiting macrophage co-stimulatory function. J Immunol 1992: 148: 3133–3139. 64 Ding L, Linsley PS, Huang L-Y, Germain RN, Shevach EM. IL-10 inhibits macrophage costimulatory activity by selectively inhibiting the up-regulation of B7 expression. J Immunol 1993: 151: 1224–1234. 65 Distel M, Mueller C, Bluhmki E, Fries J. Safety of meloxicam: a global analysis of clinical trials. Br J Rheumatol 1996: 35(Suppl 1): 68–77. 66 Donahue RE, Wang EA, Stone DK, Kamen R, Wong GG, Sehgal PK, Nathan DG, Clark SC. Stimulation of haematopoiesis in primates by continuous infusion of recombinant human GM-CSF. Nature 1986: 321: 872–875. 67 Dongari-Bagtzoglou A, Ebersole J. Production of inflammatory mediators and cytokines by human gingival fibroblasts following bacterial challenge. J Periodont Res 1996: 31: 90–98. 68 Donnelly RP, Fenton MJ, Finbloom DS, Gerrard TL. Differential regulation of IL-1 production in human monocytes by IFN-γ and IL-4. J Immunol 1990: 145: 569–575. 69 Drevlow B, Lovis R, Haag M, Sinacore J, Jacobs C, Blosch C, Beck C, Landay A, Moreland L, Pope R. Phase I study of recombinant human interleukin-1 receptor (RHUIL-1R) administered subcutaneously in patients with active rheumatoid arthritis. Arthritis Rheum 1994: 37: S339 (abstr 1070). 70 Dubois CM, Ruscetti FW, Palaszynski EW, Falk LA, Oppenheim JJ, Keller JR. Transforming growth factor β is a potent inhibitor of interleukin 1 (IL-1) receptor expression: proposed mechanism of inhibition of IL-1 action. J Exp Med 1990: 172: 737–744. 71 DuBois R, Awad J, Morrow J, Roberts L, Bishop P. Regulation of eicosanoid production and mitogenesis in rat intestinal epithelial cells by transforming growth factor-α and phorbol ester. J Clin Invest 1994: 93: 493–498. 72 Eastcott JW, Yamashita K, Taubman MA, Harada Y, Smith DJ. Adoptive transfer of cloned T helper cells ameliorates periodontal disease in nude rats. Oral Microbiol Immunol 1994: 9: 284–289. 73 Ebersole J Singer R, Steffensen B, Filloon T, Kornman KS. Inflammatory mediators and immunogloblulins in GCF from healthy, gingivitis and periodontitis sites. J Periodont Res 1993: 28: 543–546. 74 Ebersole JL, Taubman MA. The protective nature of host responses in periodontal diseases. Periodontol 2000 1994: 5: 112–141. 75 El Attar TM. Prostaglandin E2 in human gingiva in health and disease and its stimulation by female sex steroids. Prostaglandins 1976: 11: 331–341. 76 El Attar T, Lin H. Prostaglandins in gingiva of patients with periodontal disease. J Periodontol 1981: 52: 16–19. 77 El Attar T, Lin H. Relative conversion of arachidonic acid through lipoxygenase and cyclooxygenase pathways by homogenates of diseased periodontal tissues. J Oral Pathol 1983: 12: 7–10. 78 El Attar T, Lin H, Tira D. Arachidonic acid metabolism in inflamed gingiva and its inhibition by anti-inflammatory drugs. J Periodontol 1984: 55: 536–539. 79 El Attar T, Lin H. Prostaglandin E2 antagonizes gingival fibroblast proliferation stimulated by interleukin-1β. Prostaglandins Leukotr Essen Fatty Acids 1993: 49: 847–850. 80 Elliott M, Maini R. Anti-cytokine therapy in rheumatoid arthritis. Baillière's Clin Rheumatol 1995: 9: 633–652. 81 Elliot M, Maini R, Feldman M, Kalden JR, Antoni C, Smolen JS, Leeb B, Breedveld FC, Macfarlane JD, Bijl H. Randomised double-blind comparison of chimeric monoclonal antibody to tumor necrosis factor α (cA2) versus placebo in rheumatoid arthritis. Lancet 1994: 344 (8930): 1105–1110. 82 Elliot M, Maini R, Feldman M, Long-Fox A, Charles P, Bijl H, Woody JN. Repeated therapy with monoclonal antibody to tumor necrosis factor α (cA2) in patients with rheumatoid arthritis. Lancet 1994: 344: 1125–1128. 83 Ellis SD, Tucci MA, Serio FG, Johnson RB. IL-12 in periodontal disease. J Dent Res 1996: 75: 322 (abstr 2440). 84 Engelhardt G, Bogel R, Schnitzler C, Utzmann R. Meloxicam: influence on arachidonic acid metabolism. II. In vivo findings. Biochem Pharmacol 1996: 51: 29–38. 85 Enk AH, Angeloni VL, Udey MC, Katz SI. Inhibition of Langerhans cell antigen-presenting function by IL-10. J Immunol 1993: 150: 4754–4765. 86 Essner R, Rhoades K, McBride WH, Morton DL, Economou JS. IL-4 down-regulates IL-1 and TNF gene expression in human monocytes. J Immunol 1989: 142: 3857–3861. 87 Evans RT, Klausen B, Sojar HT, Bedi GS, Sfintescu C, Ramamurthy NS, Golub LM, Genco RJ. Immunization with Porphyromonas (Bacteroides) gingivalis fimbriae protects against periodontal destruction. Infect Immun 1992: 60: 2926–2935. 88 Fabry Z, Sandor M, Gajewski TF, Herlein JA, Waldschmidt MM, Lynch RG, Hart MN. Differential activation of Th1 and Th2 CD4+ cells by murine brain microvessel endothelial cells and smooth muscle/pericytes. J Immunol 1993: 151: 38–47. 89 Ferkol T, Kaetzel C, Davis P. Gene transfer into respiratory epithelial cells by targeting the polymeric immunoglobulin receptor. J Clin Invest 1993: 92: 2394–2400. 90 Finkelman FD, Katona IM, Mosmann TR, Coffman RL. IFN-γ regulates the isotypes of Ig secreted during in vivo humoral immune responses. J Immunol 1988: 140: 1022–1027. 91 Fiorentino DF, Zlotnik A, Vieira P, Mosmann TR, Howard M, Moore KW, O'Garra A. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J Immunol 1991: 146: 3444–3451. 92 Frankenburg S, Kofsky Y, Gross A. In vitro secretion of cytokines by human mononuclear cells of individuals during and after cutaneous leishmaniasis infection. Parasite Immunol 1993: 15: 509–512. 93 Freeman S, Abboud C, Whartenby KA, Packman CH, Koeplin DS, Moolten FL, Abraham GN. The "bystander effect." Tumor regression when a fraction of the tumor mass is genetically modified. Cancer Res 1993: 53: 5274–5283. 94 Fu JY, Masferrer JL, Seibert S, Raz A, Needleman P. The induction and suppression of prostaglandin H2 synthase (cyclooxygenase) in human monocytes. J Biol Chem 1990: 265: 16737–16740. 95 Fujihashi K, Kono Y, Yamamoto M, McGhee JR, Beagley K, Aicher WK, Kiyono H. Interleukin production by gingival mononuclear cells isolated from adult periodontitis patients. J Dent Res 1991: 70: 550 (abstr 2269). 96 Fujihashi K, Yamamoto M, McGhee JR, Kiyono H. Type 1/Type 2 cytokine production by CD4+ T cells in adult periodontitis. J Dent Res 1994: 73: 204 (abstr 818). 97 Gaffer A, Scherl D, Afflitto J, Coleman E. The effect of triclosan on mediators of gingival inflammation. J Clin Periodontol 1995: 22: 480–484. 98 Gajewski TF, Pinnas M, Wong T, Fitch FW. Murine Th1 and Th2 clones proliferate optimally in response to distinct antigen-presenting cell populations J Immunol 1991: 146: 1750–1758. 99 Garrison S, Holt S, Nichols F. Lipopolysaccharide-stimulated PGE2 release from human monocytes. J Periodontol 1988: 59: 684–687. 100 Ge T, Hughes H, Junquero DC, Wu KK, Vanhoutte PM, Boulanger CM. Endothelium-dependent contractions are associated with both augmented expression of prostaglandin H synthase-1 and hypersensitivity to prostaglandin H2 in the SHR aorta. Circ Res 1995: 76: 1003–1010. 101 Gemmell E, Feldner B, Seymour GJ. CD45RO and CD45RA positive cells in peripheral blood and periodontal lesions before and after stimulation with Porphyromonas gingivalis and Fusobacterium nucleatum. Oral Microbiol Immunol 1992: 7: 84–88. 102 Gemmell E, Kjeldsen M, Yamazaki K, Nakajima T, Aldred MJ, Seymour GJ. Cytokine profiles of Porphyromonas gingivalis-reactive T lymphocyte lines and clones derived from P. gingivalis-infected subjects. Oral Dis 1995: 1: 139–146. 103 Gemmell E, Seymour GJ. Interleukin 1, interleukin 6 and transforming growth factor-β production by human gingival mononuclear cells following stimulation with Porphyromonas gingivalis and Fusobacterium nucleatum. J Periodont Res 1992: 28: 122–129. 104 Gemmell E, Seymour GJ. Modulation of immune responses to periodontal bacteria. Curr Opin Periodontol 1994: 28–38. 105 Genco RJ, Mashimo PA, Krygier G, Ellison SA. Antibody-mediated effects on the periodontium. J Periodontol 1974: 45: 330–337. 106 Genco RJ, Zambon JJ, Christersson LA. The origin of periodontal infections. Adv Dent Res 1988: 2: 245–259. 107 Geng Y, Blanco F, Cornelisson M, Lotz M. Regulation of cyclooxygenase-2 expression in normal human articular chondrocytes. J Immunol 1995: 155: 796–801. 108 Ghezzi P, Dinarello CA. IL-1 induces IL-1. 3. Specific inhibition of IL-1 production by IFN-γ. J Immunol 1988: 140: 4238–4244. 109 Gierse JK, Hauser SD, Creely DP, Koboldt C, Rangwala SH, Isajson PC, Siebert K. Expression and selective inhibition of the constitutive and inducible forms of human cyclooxygenase. Biochem J 1995: 305(part 2): 479–484. 110 Gilboa E. Immunotherapy of cancer with genetically modified tumor vaccines. Semin Oncol 1996: 23: 101–107. 111 Goldhaber P. Tissue culture studies of bone as a model system for periodontal research. J Dent Res 1971: 50: 278–285. 112 Goldhaber P, Rabadjija L, Beyer WR, Kornhauser A. Bone resorption in tissue culture and its relevance to periodontal disease. J Am Dent Assoc 1973: 87: 1027–1033. 113 Golumbeck PT, Lazenby AJ, Levitsky HI, Jaffee LM, Karasuyama H, Baker M, Pardoll DM. Treatment of established renal cancer by tumour cells engineered to secrete interleukin-4. Science 1991: 254: 713–716. 114 Gomes BD, Hausmann E, Wienfeld N, De Luca C. Prostaglandins: bone resorption stimulating factors released from monkey gingiva. Calcif Tissue Res. 1976: 19: 285–293. 115 Goodson JM, Derwhirst F, Brunetti A. Prostaglandin E2 levels and human periodontal disease. Prostaglandins 1974: 6: 81–85. 116 Graham BS, Henderson GS, Tang Y-W, Lu X, Neuzil KM, Colley DG. Priming immunization determines T helper cytokine mRNA expression patterns in lungs of mice challenged with respiratory syncytial virus. J Immunol 1993: 151: 2032–2040. 117 Granowitz EV, Clark BD. Effect of interleukin-1 (IL-1) blockade on cytokine synthesis: IL-1 receptor antagonist inhibits IL-1 induced cytokine synthesis and blocks the binding of IL-1 to its type II receptor on human monocytes. Blood 1992: 79: 2356–2363. 118 Grim E, Mazumder A, Zhang H, Rosenberg S. Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes. J Exp Med 1982: 155: 1823–1841. 119 Griswold DE, Hillegass LM, Breton JJ, Esser KM, Adams JL. Differentiation in vivo of classical non-steroidal antiinflammatory drugs from cytokine-suppressive antiinflammatory drugs and other pharmacological classes using mouse tumour necrosis factor alpha production. Drugs Exp Clin Res 1993: 19: 243–248. 120 Griswold DE, Marshall PJ, Lee JC, Webb EF, Hillegass LM, Wartell J, Newton J Jr, Hanna N. Pharamcology of the pyrroloimidazole, SK&F 105809. II. Antiinflammatory activity and inhibition of mediator production in vivo. Biochem Pharmacol 1991: 42: 824–831. 121 Grossman M, Raper S, Kozarsky K, Stein E, Engelhardt J, Muller D, Lupien PJ, Wilson JM. Successful ex vivo gene therapy directed to liver in a patient with familial hypercholesterolaemia. Nature Genet 1994: 6: 335–341. 122 Grove KL, Guo X, Liu SH, Gao Z, Chu CK, Cheng YC. Anticancer activity of beta-L-dioxolane-cytidine, a novel nucleoside analogue with the unnatural L configuration. Cancer Res 1995: 55: 3008–3011. 123 Hamblin AS. In: D Male, ed. Cytokines and cytokine receptors. Oxford : Oxford University Press, 1993. 124 Hammerberg C, Arend W, Fisher G, Chan L, Berger A, Haskill J, Voorhees J, Cooper K. Interleukin-1 receptor antagonist in normal and psoriatic epidermis. J Clin Invest 1992: 90: 571–583. 125 Hanania E, Fu S, Zu Z, Hegewisch Becker S, Korbling M, Hester J, Durett A, Andreeff M, Mechetner E, Holzmayer T, Roninson I, Giles E, Berenson R, Heimfeld S, Deisscroth A. Chemotherapy resistance to taxol in clonogenic progenitor cells following transduction of CD34 selected marrow and peripheral blood cells with a retrovirus that contains the MDR-1 chemotherapy resistance gene. Gene Ther 1995: 2: 285–294. 126 Hanania E, Kavanagh J, Hortobagyi G, Giles R, Champlin R, Deisseroth A. Recent advances in the application of gene therapy to human disease. Am J Med 1995: 99: 537–552. 127 Harrell J, Stein S. Prostaglandin E2 regulates gingival mononuclear cell immunoglobulin production. J Periodontol 1995: 66: 222–227. 128 Harvey W, Bennett A. Prostaglandins in bone resorption. Boca Raton , FL : CRC Press, 1988. 129 Heasman P, Benn DK, Kelly P, Seymour R, Aitken D. The use of topical flurbiprofen as an adjunct to non-surgical management of periodontal disease. J Clin Periodontol 1993: 20: 457–464. 130 Heasman P., Collins J, Offenbacher S. Changes in crevicular fluid levels of interleukin-1β, leukotriene B4, prostaglandin E2, thromboxane B2 and tumour necrosis factor α in experimental gingivitis in humans. J Periodont Res 1993: 28: 241–247. 131 Heasman P, Offenbacher S, Collins J, Edwards G, Seymour R. Flurbiprofen in the prevention and treatment of experimental gingivitis. J Clin Periodontol 1993: 20: 732–728. 132 Heasman PA, Seymour R. The effect of a systemically-administered non-steroidal anti-inflammatory drug (flurbiprofen) on experimental gingivitis in humans. J Clin Periodontol 1989: 16: 551–556. 133 Heasman P, Seymour R, Kelly P. The effect of systemically-administered flurbiprofen as an adjunct to toothbrushing on resolution of experimental gingivitis. J Clin Periodontol 1994: 21: 166–170. 134 Hendley TM, Steed RB, Galbraith GMP. Interleukin-1β gene expression in human oral polymorphonuclear leukocytes. J Periodontol 1995: 66: 761–765. 135 Higuchi M, Aggarwal BB. Modulation of two forms of tumor necrosis factor receptors and their cellular response by soluble receptors and their monoclonal antibodies. J Biol Chem 1992: 267: 20892–20899. 136 Honig J, Rordorf-Adam C, Siegmund C, Wiedemann W, Erard F. Interleukin-1 beta (IL-1β) concentration in gingival tissue from periodontitis patients and healthy control subjects. J Periodont Res 1989: 24: 362–367. 137 Hoogerbrugge P, Vassen J, Beusechann V, Valerio D. Treatment of patients with SCID due to ADA deficiency by autologous transplantation of ge
Referência(s)